{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:24:25Z","timestamp":1791267865208,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/inf.0000000000000251","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T11:06:51Z","timestamp":1390216011000},"page":"741-746","source":"Crossref","is-referenced-by-count":20,"title":["First Trimester Exposure to Antiretroviral Therapy and Risk of Birth Defects"],"prefix":"10.1097","volume":"33","author":[{"given":"Kelesitse","family":"Phiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hernandez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate B.","family":"Dugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astride","family":"Jules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Todd","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Seage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210202","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bmj.39176.674977.AD","article-title":"HIV and pregnancy.","volume":"334","author":"Gray","year":"2007","journal-title":"BMJ"},{"key":"R5-15-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00002030-200201250-00025","article-title":"Myelomeningocele in a child with intrauterine exposure to efavirenz.","volume":"16","author":"Fundaro","year":"2002","journal-title":"AIDS"},{"key":"R6-15-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archinte.162.3.355","article-title":"Periconceptional exposure to efavirenz and neural tube defects.","volume":"162","author":"De Santis","year":"2002","journal-title":"Arch Intern Med"},{"key":"R8-15-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/QAD.0b013e328333af32","article-title":"Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital.","volume":"24","author":"Bera","year":"2010","journal-title":"AIDS"},{"key":"R9-15-20210202","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/QAD.0b013e328326ca8e","article-title":"Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.","volume":"23","author":"Townsend","year":"2009","journal-title":"AIDS"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/INF.0b013e3181e74a2f","article-title":"Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.","volume":"29","author":"Brogly","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R11-15-20210202","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QAI.0b013e3181c5c81f","article-title":"NISDI Perinatal Study Group. Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.","volume":"53","author":"Joao","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-15-20210202","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/INF.0b013e318235c7aa","article-title":"Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.","volume":"31","author":"Knapp","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/jpm.2010.139","article-title":"Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.","volume":"39","author":"Watts","year":"2011","journal-title":"J Perinat Med"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/QAI.0b013e31802e2229","article-title":"Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study.","volume":"44","author":"Watts","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-15-20210202","first-page":"116","article-title":"European Collaborative Study.","volume":"40","author":"Patel","year":"2005","journal-title":"Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women J Acquir Immune Defic Syndr"},{"key":"R16-15-20210202","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/oxfordjournals.aje.a115198","article-title":"Use of Medicaid data for pharmacoepidemiology.","volume":"129","author":"Ray","year":"1989","journal-title":"Am J Epidemiol"},{"key":"R17-15-20210202","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJMp038145","article-title":"Population-based studies of adverse drug effects.","volume":"349","author":"Ray","year":"2003","journal-title":"N Engl J Med"},{"key":"R18-15-20210202","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jclinepi.2006.10.019","article-title":"Understanding secondary databases: a commentary on Sources of bias for health state characteristics in secondary databases.","volume":"60","author":"Schneeweiss","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"R19-15-20210202","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors.","volume":"354","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"key":"R20-15-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-3016.2008.00978.x","article-title":"Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.","volume":"23","author":"Cooper","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R22-15-20210202","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/pds.1534","article-title":"Positive predictive value of computerized records for major congenital malformations.","volume":"17","author":"Cooper","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R23-15-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/tera.1420430106","article-title":"Risk factors for birth defects: data from the Atlanta Birth Defects Case-Control Study.","volume":"43","author":"Erickson","year":"1991","journal-title":"Teratology"},{"key":"R24-15-20210202","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/oxfordjournals.aje.a115692","article-title":"Methodological issues in evaluating expanded Medicaid coverage for pregnant women.","volume":"132","author":"Piper","year":"1990","journal-title":"Am J Epidemiol"},{"key":"R25-15-20210202","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/bdra.20842","article-title":"Inclusion and exclusion criteria for malformations in newborn infants exposed to potential teratogens.","volume":"91","author":"Holmes","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R28-15-20210202","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/bdra.20065","article-title":"Maternal age and non-chromosomal birth defects, Atlanta-1968-2000: teenager or thirty-something, who is at risk.","volume":"70","author":"Reefhuis","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R29-15-20210202","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/003335491212700106","article-title":"Racialethnic variations in the prevalence of selected major birth defects, metropolitan Atlanta, 1994-2005.","volume":"127","author":"Kucik","year":"2012","journal-title":"Public Health Rep"},{"key":"R31-15-20210202","first-page":"17","article-title":"Efavirenz reclassified as FDA pregnancy category D.","volume":"17","author":"Mofenson","year":"2005","journal-title":"AIDS Clin Care"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:02:50Z","timestamp":1620954170000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201407000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000251","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}